Surgery Partners Secures Binding Escrow Agreement for $1.15 Billion Sale of Idaho Hospitals to Intermountain Health

Transaction Structure and Escrow Details

On July 21, 2026, Surgery Partners and Intermountain Health formalized a transaction framework incorporating an escrow mechanism to safeguard both parties during the approval phase. The binding agreement deposits signature pages for two separate Securities Purchase Agreements into escrow, with their release dependent on meeting specified conditions. This structure ensures a firm contractual commitment while allowing time for internal governance and regulatory reviews to progress.

Escrow release requires approvals from Mountain View Hospital's physician members and governing board. Surgery Partners must also certify that all representations and warranties remain accurate as of the release date, with no material facts necessitating new or amended disclosures. Any required disclosures must be mutually acceptable prior to escrow release. This dual-condition mechanism reflects the complex stakeholder environment typical of hospital asset sales involving physician ownership interests.

Valuation and Anticipated Proceeds

The combined assets—Mountain View Hospital, LLC and Idaho Falls Community Hospital, LLC—are valued at approximately $1.15 billion in the proposed sale to Intermountain Health. Surgery Partners is slated to receive roughly $795 million in gross proceeds before standard purchase price adjustments, which will account for indebtedness, working capital balances at closing, transaction expenses, and other customary closing items.

The company notes it cannot currently estimate final net cash proceeds due to the uncertainty of these adjustments. This highlights the potential impact of debt repayment, working capital normalization, and closing costs on the ultimate cash inflow. Investors should consider this variability when evaluating the transaction’s financial benefits.

Hospital Portfolio and Physician Ownership Continuity

The divested properties include two interconnected Idaho hospitals central to Surgery Partners’ hospital operations segment. Notably, physician ownership of Mountain View Hospital will remain intact despite Surgery Partners transferring its ownership interests to Intermountain Health. This arrangement underscores the importance of physician leadership and investment in the hospital’s governance and strategic direction.

By preserving physician ownership while transferring Surgery Partners’ stake, the transaction balances Intermountain Health’s consolidation goals with ongoing physician involvement. This structure aims to minimize disruption to clinical operations and physician relationships during the transition. The requirement for physician member and governing board approvals prior to escrow release further emphasizes the significant influence of physician stakeholders in the transaction.

Regulatory and Closing Conditions

Completion of the transaction depends on satisfying multiple regulatory and contractual conditions beyond escrow release. Key among these is clearance under the Hart-Scott-Rodino Act, the federal premerger notification process overseen by the FTC and DOJ. Given the transaction’s size and healthcare sector sensitivities, this review may involve in-depth competitive analysis and potential second-request inquiries, potentially extending the approval timeline. The transaction cannot close until the Hart-Scott-Rodino waiting period expires.

Additional approvals may include state hospital licensing, attorney general reviews, health department authorizations, and insurance commissioner approvals, depending on related arrangements. The deal also requires material third-party consents, which could involve payer contracts, physician agreements, equipment leases, or facility licenses. These extensive conditions present notable execution risks for closing the transaction.

Outside Termination Date and Extensions

The definitive agreements set an outside termination date at 60 days after escrow signature release, serving as a final deadline for closing. Either party may terminate the deal if closing does not occur by this date without further pursuit of approvals. However, extensions to this deadline are possible under unspecified circumstances, which may be critical if regulatory reviews, particularly Hart-Scott-Rodino examinations, require additional time.

This structure balances contractual certainty with flexibility to accommodate regulatory timelines. For Surgery Partners shareholders, the outside date marks a key milestone for transaction progress or potential delays. The company’s current inability to commit to a firm closing date reflects inherent uncertainties in regulatory approvals for healthcare deals of this scale.

Representations, Warranties, and Indemnification Provisions

The Securities Purchase Agreements include standard representations and warranties from both parties concerning the divested assets’ legal, financial, and operational status. These cover entity legality, absence of undisclosed liabilities, regulatory compliance, and accuracy of financial disclosures. Covenants binding the parties during the pre-closing period likely address operational continuity, maintenance of payer and provider relationships, and restrictions on material business changes.

Indemnification provisions establish mechanisms for loss recovery in cases of breaches, typically through escrow holdbacks retained for 12 to 24 months post-closing. While specific terms such as survival periods, baskets, and caps are not detailed here, these negotiated provisions allocate post-closing risks and are important for investors assessing Surgery Partners’ residual liabilities.

Strategic Rationale Behind the Divestiture

Surgery Partners’ sale of Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health aligns with broader healthcare consolidation trends, where smaller operators face pressure to integrate with larger systems or exit markets. This portfolio management move transfers two key Idaho assets to a regional health system with greater scale and capital, generating approximately $795 million in gross proceeds before adjustments.

The proceeds provide Surgery Partners with liquidity to reduce debt, enhance remaining operations, or pursue strategic acquisitions in markets where it holds competitive advantages. For Intermountain Health, the acquisition expands its Mountain West footprint, adding hospital capacity and service lines that may yield operational efficiencies through consolidated procurement, shared clinical services, and unified payer contracting. Preserving physician ownership stakes supports smoother transitions and maintains clinical stakeholder relationships.

Post-Announcement Disclosures and Regulatory Filings

On July 24, 2026, three days after escrow placement, Surgery Partners publicly announced the binding agreement via a press release filed as Exhibit 99.1 to its current report. This disclosure satisfied SEC requirements for timely material information release under Regulation FD, while not constituting a formal "filed" document under Section 18 of the Securities Exchange Act, thereby limiting securities law liability for forward-looking statements.

This regulatory approach ensures transparency regarding the transaction while managing legal exposure, consistent with standard practices for material event announcements.

Transaction Timeline, Approvals, and Investor Considerations

Key upcoming milestones include escrow signature release contingent on physician approvals and certification of representations. Following release, the 60-day (extendable) outside closing date commences, during which Hart-Scott-Rodino clearance, state and federal regulatory approvals, and third-party consents must be secured. Each approval stage carries execution risks that could affect closing timing.

Investors should monitor physician member and governing board decisions at Mountain View Hospital, as well as developments in federal premerger review, including any second requests. Public updates on state regulatory clearances, third-party consents, and closing will provide indicators of transaction progress. Subsequent quarterly and annual filings will offer updated disclosures on status, timing, and material changes.

Financial and Strategic Impact for Surgery Partners Shareholders

The anticipated $795 million in gross proceeds will significantly influence Surgery Partners’ balance sheet and capital strategy upon closing. Representing a substantial portion of the company’s hospital operations portfolio, the divestiture proceeds may be allocated toward debt reduction, growth investments, shareholder returns, or strategic acquisitions to strengthen competitive positioning.

Strategically, the sale highlights Surgery Partners’ focus on markets and segments where it holds competitive advantages, divesting non-core Idaho assets to a larger regional competitor. This disciplined portfolio management aligns with best practices amid healthcare services consolidation, providing investors with insight into management’s priorities and responsiveness to market dynamics.